Orgenesis Enters into Collaboration Agreement with the Bambino Gesù Children’s Hospital in Rome to Establish Point of Care Cell and Gene Therapy Center

GERMANTOWN, Md., March 29, 2021 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene therapies, announces that it has entered a collaboration with the Bambino Gesù Children's Hospital in Rome to establish a Point of Care Cell Therapy center...
Read More

CyanVac selects Exothera for the development and GMP manufacturing of its COVID-19 intranasal vaccine candidate for phase III clinical trial in Europe and the US

Athens, Georgia, USA – March 24, 2021 – CyanVac LLC, a vaccine company, announced today that they have selected Exothera S.A., a full-service Contract Development and Manufacturing Organization (CDMO), for the development and manufacturing of their COVID-19 intranasal vaccine based on a proprietary parainfluenza virus 5 (PIV5) vector. Exothera will be...
Read More

HealthTech For Care and EIT Health renew their partnership for the organisation of HealthTech Innovation Days, reinforcing its European positioning through new collaborations with BIO Deutschland and BioWin.

HealthTech For Care and EIT Health renew their partnership for the organisation of HealthTech Innovation Days, reinforcing its European positioning through new collaborations with BIO Deutschland and BioWin. These partnerships, which reinforce the international dimension of the HealthTech Innovation Days, will facilitate collaborations within the European health ecosystem with the…

Read More

BioWin announces expanded role to consolidate Wallonia’s status as a dynamic region for life science innovation

BioWin announces expanded role to consolidate Wallonia’s status as a dynamic region for life science innovation Gosselies, Belgium, March 2nd, 2021 – BioWin, the health cluster of Wallonia, today announced its evolution from an organization focused on collaborative research and innovation project support to one offering a much wider range…

Read More